Neumora Therapeutics's long-term debt is $41K.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (June 2026), NMRA shows a long-term debt of $41K. That compares with $340K in the prior-year period — down 87.9% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, NMRA's long-term debt is now $41K (was $340K) — a 87.9% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Neumora Therapeutics is outperforming or lagging.
Tracking NMRA's long-term debt over time shows whether Neumora Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $41K That compares with $340K in the prior-year period — down 87.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this long-term debt page, Stockcircle has Neumora Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $41K) with ownership activity and broader fundamentals.